947.8K XNAS Volume
XNAS 08 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Neal Walker | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,467 | 1,476,374 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.48 per share. | 01 Apr 2025 | 3,042 | 1,473,332 (3%) | 0% | 1.5 | 4,502 | Common Stock |
| Neal Walker | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,467 | 9,467 | - | - | Restricted Stock Units | |
| Neal Walker | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 9,466 | 18,934 | - | - | Restricted Stock Units | |
| Neal Walker | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 01 Mar 2025 | 3,277 | 1,466,907 (3%) | 0% | 2.0 | 6,521 | Common Stock |
| Neal Walker | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 9,466 | 1,470,184 (3%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 50,000 | 281,995 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 01 Mar 2025 | 27,258 | 265,662 (0%) | 0% | 2.0 | 54,243 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 10,925 | 292,920 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 10,925 | 10,925 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,100 | 0 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,375 | 93,335 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,100 | 90,960 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,375 | 2,375 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 01 Mar 2025 | 727 | 92,608 (0%) | 0% | 2.0 | 1,447 | Common Stock |
| Hugh Davis | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 261,600 | 261,600 | - | - | Employee Stock Option (Right to Buy) | |
| Hugh Davis | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 74,700 | 74,700 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 9,467 | 1,464,277 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 9,467 | 28,400 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 888,800 | 888,800 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director, INTERIM CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 253,900 | 253,900 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Feb 2025 | 3,559 | 1,460,718 (3%) | 0% | 2.5 | 8,826 | Common Stock |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 44,250 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 83,500 | 83,500 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 292,300 | 292,300 | - | - | Employee Stock Option (Right to Buy) | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 11,250 | 96,503 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 104,003 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 118,753 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Feb 2025 | 15,447 | 103,306 (0%) | 0% | 2.5 | 38,309 | Common Stock |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 11,250 | 11,250 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 15,000 | - | - | Resticted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 293,500 | 293,500 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 228,562 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 243,312 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Feb 2025 | 11,317 | 231,995 (0%) | 0% | 2.5 | 28,066 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 7,500 | 15,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 44,250 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 83,900 | 83,900 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Feb 2025 | 5,816 | 89,860 (0%) | 0% | 2.5 | 14,424 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 44,250 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 88,100 | 88,100 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 308,200 | 308,200 | - | - | Employee Stock Option (Right to Buy) | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,750 | 95,676 (0%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 9,467 | 1,443,097 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Jan 2025 | 3,904 | 1,439,193 (3%) | 0% | 2.5 | 9,682 | Common Stock |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 29,149 | 1,468,342 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 01 Jan 2025 | 13,532 | 1,454,810 (3%) | 0% | 2.5 | 33,559 | Common Stock |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 9,467 | 37,867 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 88,333 | 88,333 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 29,149 | 59,184 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 18,150 | 36,850 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 107,767 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 31 Dec 2024 | 32,089 | 75,678 (0%) | 0% | 2.5 | 79,581 | Common Stock |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 18,150 | 93,828 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 31 Dec 2024 | 8,575 | 85,253 (0%) | 0% | 2.5 | 21,266 | Common Stock |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 73,750 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Dec 2024 | 32,937 | 212,596 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 17,380 | 35,287 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 52,667 | 52,667 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 73,750 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 31 Dec 2024 | 8,914 | 221,062 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 17,380 | 229,976 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 245,533 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 7,500 | 15,000 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 13,200 | 26,800 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 7,500 | 75,215 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 31 Dec 2024 | 30,732 | 67,715 (0%) | 0% | 2.5 | 76,215 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 98,447 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 31 Dec 2024 | 2,430 | 72,785 (0%) | 0% | 2.5 | 6,026 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 13,200 | 85,985 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.48 per share. | 31 Dec 2024 | 5,059 | 80,926 (0%) | 0% | 2.5 | 12,546 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 73,750 | 73,750 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2024 | 15,000 | 171,783 (0%) | 0% | 0 | Common Stock | |
| Neal Walker | Director, INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 04 Dec 2024 | 68,343 | 1,433,630 (3%) | 0% | 3.8 | 256,970 | Common Stock |
| Walker Neal | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2024 | 118,840 | 0 | - | - | Employee Stock Option (right to buy) | |
| Walker Neal | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.52 per share. | 04 Dec 2024 | 118,840 | 1,501,973 (3%) | 0% | 1.5 | 180,637 | Common Stock |
| Hugh Davis | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 107,000 | 107,000 | - | - | Restricted Stock Units | |
| Hugh Davis | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 375,000 | 375,000 | - | - | Employee Stock Option (Right to Buy) | |
| Walker Neal | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 9,466 | 47,334 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 9,466 | 1,385,854 (3%) | 0% | - | Common Stock | |
| Walker Neal | Director, INTERIM CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.07 per share. | 01 Dec 2024 | 2,721 | 1,383,133 (3%) | 0% | 4.1 | 11,074 | Common Stock |
| Anand Mehra | Director | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 19 Nov 2024 | 666,666 | 710,030 (1%) | 1% | 2.3 | 1,499,999 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 9,467 | 56,800 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 01 Nov 2024 | 2,721 | 1,376,388 (3%) | 0% | 2.1 | 5,687 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 9,467 | 1,379,109 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 9,467 | 1,372,364 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 9,467 | 66,267 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 01 Oct 2024 | 2,722 | 1,369,642 (3%) | 0% | 1.2 | 3,212 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 9,466 | 1,365,619 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 9,466 | 75,734 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 01 Sep 2024 | 2,722 | 1,362,897 (3%) | 0% | 1.2 | 3,212 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 01 Sep 2024 | 286 | 24,697 (0%) | 0% | 1.2 | 337 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,000 | 24,983 (0%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.72 per share. | 09 Aug 2024 | 43,548 | 1,356,153 (3%) | 0% | 0.7 | 31,355 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 43,548 | 0 | - | - | Employee Stock Option (right to buy) | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 01 Aug 2024 | 2,722 | 1,312,605 (3%) | 0% | 1.3 | 3,593 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 9,467 | 85,200 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 9,467 | 1,315,327 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 9,467 | 94,667 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 9,467 | 1,308,582 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 01 Jul 2024 | 2,722 | 1,305,860 (3%) | 0% | 1.1 | 3,130 | Common Stock |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 4,793 | 4,793 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 16,961 (0%) | 0% | - | Common Stock | |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 12,523 (0%) | 0% | - | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 33,523 (0%) | 0% | - | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 9,167 (0%) | 0% | - | Common Stock | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 28,732 (0%) | 0% | - | Common Stock | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 43,364 (0%) | 0% | - | Common Stock | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 9,466 | 1,301,837 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.03 per share. | 01 Jun 2024 | 2,722 | 1,299,115 (3%) | 0% | 1.0 | 2,804 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 9,466 | 104,134 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 53,163 (0%) | 0% | - | Common Stock | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 28,732 (0%) | 0% | - | Common Stock | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 4,660 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 9,467 | 113,600 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 01 May 2024 | 2,784 | 1,292,371 (3%) | 0% | 1.3 | 3,508 | Common Stock |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 9,467 | 1,295,155 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 9,467 | 1,288,912 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 9,467 | 123,067 | - | - | Restricted Stock Units | |
| Neal Walker | Director, INTERIM PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 01 Apr 2024 | 3,224 | 1,285,688 (3%) | 0% | 1.3 | 4,062 | Common Stock |
| Andrew Kenneth Williams Powell | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 01 Mar 2024 | 8,500 | 22,863 (0%) | 0% | 1.2 | 10,455 | Common Stock |
| Andrew Kenneth Williams Powell | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 01 Mar 2024 | 6,000 | 28,863 (0%) | 0% | 1.3 | 7,500 | Common Stock |
| Neal Walker | Director, Interim President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 9,466 | 1,282,668 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, Interim President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 9,466 | 132,534 | - | - | Restricted Stock Units | |
| Neal Walker | Director, Interim President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 3,223 | 1,279,445 (3%) | 0% | 1.2 | 3,997 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 14,569 | 170,072 (0%) | 0% | 1.2 | 18,066 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 50,000 | 184,641 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 0 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 10,925 | 21,850 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 190,314 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 3,531 | 186,783 (0%) | 0% | 1.2 | 4,378 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 3,183 | 177,814 (0%) | 0% | 1.2 | 3,947 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 10,925 | 180,997 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,500 | 0 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,100 | 1,100 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 427 | 23,983 (0%) | 0% | 1.2 | 529 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,500 | 24,410 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 677 | 22,910 (0%) | 0% | 1.2 | 839 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,375 | 23,587 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 01 Mar 2024 | 313 | 21,212 (0%) | 0% | 1.2 | 388 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,100 | 21,525 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 2,375 | 4,750 | - | - | Restricted Stock Units | |
| Monahan Joseph | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Feb 2024 | 2,583 | 134,641 (0%) | 0% | 1.2 | 3,100 | Common Stock |
| Monahan Joseph | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 7,500 | 137,224 (0%) | 0% | - | Common Stock | |
| Loerop James | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Feb 2024 | 3,853 | 29,085 (0%) | 0% | 1.2 | 4,624 | Common Stock |
| Loerop James | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Neal Walker | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 142,000 | 142,000 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 11,250 | 32,938 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 147,500 | 147,500 | - | - | Restricted Stock Units | |
| Balthaser Kevin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 206,500 | 206,500 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 497,000 | 497,000 | - | - | Stock Option (Right to Buy) | |
| Loerop James | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 7,500 | 36,585 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 11,250 | 22,500 | - | - | Restricted Stock Units | |
| Balthaser Kevin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 01 Feb 2024 | 2,568 | 34,017 (0%) | 0% | 1.2 | 3,082 | Common Stock |
| Balthaser Kevin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 147,500 | 147,500 | - | - | Restricted Stock Units | |
| Monahan Joseph | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 206,500 | 206,500 | - | - | Employee Stock Option (Right to Buy) | |
| Loerop James | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 147,500 | 147,500 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 206,500 | 206,500 | - | - | Employee Stock Option (Right to Buy) | |
| Balthaser Kevin | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 01 Jan 2024 | 2,536 | 20,425 (0%) | 0% | 1.1 | 2,663 | Common Stock |
| Douglas Manion J. | Director, Pres and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.05 per share. | 01 Jan 2024 | 9,125 | 41,813 (0%) | 0% | 1.0 | 9,581 | Common Stock |
| Douglas Manion J. | Director, Pres and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 27,000 | 50,938 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 22,500 | - | - | Restricted Stock Units | |
| J. Manion Douglas | Director, Pres and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 27,000 | 81,000 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 22,961 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 28 Aug 2023 | 14,705 | 21,688 (0%) | 0% | 6.8 | 99,959 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.32 per share. | 21 Aug 2023 | 6,000 | 135,724 (0%) | 0% | 7.3 | 43,895 | Common Stock |
| Douglas J. Manion | Director, Pres and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 15,575 | 28,375 (0%) | 0% | - | Common Stock | |
| Douglas J. Manion | Director, Pres and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 15,575 | 46,725 | - | - | Restricted Stock Units | |
| Douglas J. Manion | Director, Pres and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.81 per share. | 01 Aug 2023 | 4,437 | 23,938 (0%) | 0% | 9.8 | 43,527 | Common Stock |
| Gail Cawkwell | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.37 per share. | 01 Jul 2023 | 5,407 | 9,593 (0%) | 0% | 10.4 | 56,071 | Common Stock |
| Gail Cawkwell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 15,000 | 45,000 | - | - | Restricted Stock Units | |
| Gail Cawkwell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 15,000 | 15,000 (0%) | 0% | - | Common Stock | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2023 | 16,500 | 0 | - | - | Stock Option (right to buy) | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 20 Jun 2023 | 16,500 | 48,503 (0%) | 0% | 1.4 | 23,265 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.28 per share. | 20 Jun 2023 | 6,000 | 141,724 (0%) | 0% | 10.3 | 61,663 | Common Stock |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.52 per share. | 15 Jun 2023 | 198 | 32,003 (0%) | 0% | 1.5 | 301 | Common Stock |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 198 | 0 | - | - | Stock Option (right to buy) | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 51 | 0 | - | - | Stock Option (right to buy) | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 15 Jun 2023 | 51 | 31,805 (0%) | 0% | 0.7 | 37 | Common Stock |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 12,301 (0%) | 0% | - | Common Stock | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 7,863 (0%) | 0% | - | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Andrew Kenneth Williams Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 14,363 (0%) | 0% | - | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 4,507 (0%) | 0% | - | Common Stock | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 24,072 (0%) | 0% | - | Common Stock | |
| Bryan M. Reasons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Bryan M. Reasons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 38,704 (0%) | 0% | - | Common Stock | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 31,754 (0%) | 0% | - | Common Stock | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,660 | 4,660 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 24,072 (0%) | 0% | - | Common Stock | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 4,507 | 0 | - | - | Restricted Stock Units | |
| Douglas J. Manion | Director, Pres and CEO | Purchase of securities on an exchange or from another person at price $ 7.86 per share. | 17 Mar 2023 | 6,300 | 12,800 (0%) | 0% | 7.9 | 49,532 | Common Stock |
| Douglas J. Manion | Director, Pres and CEO | Purchase of securities on an exchange or from another person at price $ 7.74 per share. | 09 Mar 2023 | 6,500 | 6,500 (0%) | 0% | 7.7 | 50,278 | Common Stock |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 24,000 | 72,000 | - | - | Restricted Stock Units | |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 96,150 | 1,271,913 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 18,275 | 1,290,188 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 24,000 | 1,314,188 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 12.37 per share. | 01 Mar 2023 | 29,000 | 1,285,188 (3%) | 0% | 12.4 | 358,588 | Common Stock |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 18,254 | 1,303,442 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 12.63 per share. | 01 Mar 2023 | 30,240 | 1,273,202 (3%) | 0% | 12.6 | 382,070 | Common Stock |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 96,150 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 18,275 | 36,550 | - | - | Restricted Stock Units | |
| Neal Walker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 18,254 | 18,254 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 163,761 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.63 per share. | 01 Mar 2023 | 16,037 | 147,724 (0%) | 0% | 12.6 | 202,615 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 13,750 | 0 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 100,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 10,925 | 32,775 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 13,750 | 105,136 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 155,136 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 10,925 | 166,061 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.37 per share. | 01 Mar 2023 | 14,800 | 151,261 (0%) | 0% | 12.4 | 183,024 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,475 | 2,175 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,375 | 5,650 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.29 per share. | 01 Mar 2023 | 1,000 | 4,650 (0%) | 0% | 12.3 | 12,289 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,500 | 6,150 (0%) | 0% | - | Common Stock | |
| Kevin Balthaser | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.63 per share. | 01 Mar 2023 | 894 | 5,256 (0%) | 0% | 12.6 | 11,290 | Common Stock |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,475 | 0 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,100 | 2,200 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 2,375 | 7,125 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,500 | 1,500 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,100 | 3,275 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 15 Feb 2023 | 5,000 | 91,386 (0%) | 0% | 13.1 | 65,311 | Common Stock |
| James Loerop | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 08 Feb 2023 | 4,267 | 6,983 (0%) | 0% | 13.9 | 59,272 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 01 Feb 2023 | 25,000 | 1,180,763 (2%) | 0% | 16.7 | 418,675 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 17.54 per share. | 01 Feb 2023 | 200 | 1,175,763 (2%) | 0% | 17.5 | 3,507 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 16.88 per share. | 01 Feb 2023 | 3,121 | 1,175,963 (2%) | 0% | 16.9 | 52,691 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 15.55 per share. | 01 Feb 2023 | 600 | 1,179,084 (2%) | 0% | 15.6 | 9,332 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 14.57 per share. | 01 Feb 2023 | 1,079 | 1,179,684 (2%) | 0% | 14.6 | 15,718 | Common Stock |
| Gail Cawkwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Gail Cawkwell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 105,000 | 105,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 11,250 | 33,750 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 11,250 | 11,250 (0%) | 0% | - | Common Stock | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 105,000 | 105,000 | - | - | Employee Stock Option (Right to Buy) | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 105,000 | 105,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Douglas J. Manion | Director, Pres and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 108,000 | 108,000 | - | - | Restricted Stock Units | |
| Douglas J. Manion | Director, Pres and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 378,000 | 378,000 | - | - | Employee Stock Option (Right to Buy) | |
| Kevin Balthaser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Kevin Balthaser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 105,000 | 105,000 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 03 Jan 2023 | 23,382 | 1,222,381 (2%) | 0% | 15.2 | 355,067 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 14.89 per share. | 03 Jan 2023 | 15,000 | 1,205,763 (2%) | 0% | 14.9 | 223,343 | Common Stock |
| Neal Walker | Director | Sale of securities on an exchange or to another person at price $ 16.16 per share. | 03 Jan 2023 | 1,618 | 1,220,763 (2%) | 0% | 16.2 | 26,146 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.02 per share. | 10 Nov 2022 | 11,395 | 476,986 (1%) | 0% | 17.0 | 193,995 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.08 per share. | 10 Nov 2022 | 1,371 | 434,455 (1%) | 0% | 17.1 | 23,417 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.06 per share. | 10 Nov 2022 | 41,160 | 435,826 (1%) | 0% | 17.1 | 702,177 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.02 per share. | 24 Oct 2022 | 12,018 | 502,921 (1%) | 0% | 17.0 | 204,516 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 24 Oct 2022 | 14,540 | 488,381 (1%) | 0% | 17.0 | 247,253 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 24 Oct 2022 | 14,616 | 514,939 (1%) | 0% | 17.0 | 248,586 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 16.89 per share. | 17 Oct 2022 | 32,093 | 529,555 (1%) | 0% | 16.9 | 542,022 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 17 Oct 2022 | 19,944 | 561,648 (1%) | 0% | 16.0 | 320,087 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.98 per share. | 17 Oct 2022 | 5,000 | 101,386 (0%) | 0% | 16.0 | 79,908 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 16.16 per share. | 07 Oct 2022 | 7,324 | 581,592 (1%) | 0% | 16.2 | 118,349 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 16.54 per share. | 04 Oct 2022 | 37,839 | 588,916 (1%) | 0% | 16.5 | 625,744 | Common Stock |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 04 Oct 2022 | 7,700 | 626,755 (1%) | 0% | 16.0 | 123,259 | Common Stock |
| Douglas J. Manion | Pres and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 62,300 | 62,300 | - | - | Restricted Stock Units | |
| Douglas J. Manion | Pres and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 217,800 | 217,800 | - | - | Employee Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 17 Jun 2022 | 19,565 | 0 (0%) | 0% | 15.1 | 296,269 | Common Stock |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 7,794 (0%) | 0% | - | Common Stock | |
| Maxine Gowen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Maxine Gowen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Vincent J. Milano | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 3,356 (0%) | 0% | - | Common Stock | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Vincent J. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 13,856 (0%) | 0% | - | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew Kenneth Williams Powell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jun 2022 | 709 | 10,500 (0%) | 0% | 0 | Common Stock | |
| Andrew Kenneth Williams Powell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Andrew Kenneth Williams Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 19,565 (0%) | 0% | - | Common Stock | |
| Andrew N. Schiff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Andrew N. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Bryan M. Reasons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 19,565 (0%) | 0% | - | Common Stock | |
| Bryan M. Reasons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Bryan M. Reasons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 34,197 (0%) | 0% | - | Common Stock | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| Anand Mehra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| Christopher Molineaux | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 27,247 (0%) | 0% | - | Common Stock | |
| Christopher Molineaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 0 | - | - | Restricted Stock Units | |
| William D. Humphries | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2022 | 3,356 | 19,565 (0%) | 0% | - | Common Stock | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 15,750 | 15,750 | - | - | Stock Option (Right to Buy) | |
| William D. Humphries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,507 | 4,507 | - | - | Restricted Stock Units | |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 21 Apr 2022 | 25,000 | 1,290,763 (3%) | 0% | 15.2 | 380,948 | Common Stock |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 21 Apr 2022 | 25,000 | 1,265,763 (3%) | 0% | 15.0 | 376,098 | Common Stock |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.18 per share. | 21 Apr 2022 | 20,000 | 1,245,763 (2%) | 0% | 15.2 | 303,656 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.28 per share. | 18 Apr 2022 | 30,000 | 106,386 (0%) | 0% | 16.3 | 488,298 | Common Stock |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.91 per share. | 11 Mar 2022 | 56,303 | 1,315,763 (3%) | 0% | 15.9 | 896,045 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.55 per share. | 10 Mar 2022 | 12,823 | 201,883 (0%) | 0% | 15.5 | 199,335 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.71 per share. | 10 Mar 2022 | 27,165 | 136,386 (0%) | 0% | 15.7 | 426,803 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 18,275 | 1,353,812 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 18,254 | 36,508 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 18,275 | 54,825 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 96,150 | 96,150 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 96,000 | 96,000 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 336,100 | 336,100 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 18,254 | 1,372,066 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 96,150 | 1,335,537 (3%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 8,300 | 24,900 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 8,297 | 16,595 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 25,750 | 25,750 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 44,300 | 44,300 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 155,200 | 155,200 | - | - | Employee Stock Option (Right to Buy) | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 8,297 | 214,706 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 8,300 | 206,409 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 25,750 | 198,109 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 50,000 | 151,051 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 13,750 | 101,051 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 12,500 | 25,000 | - | - | Restricted stock units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 50,000 | 150,000 | - | - | Restricted stock units | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 13,750 | 13,750 | - | - | Restricted stock units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 43,700 | 43,700 | - | - | Restricted stock units | |
| Joseph Monahan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 153,100 | 153,100 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 12,500 | 163,551 (0%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 10,800 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 10,800 | 1,242,982 (2%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 3,875 | 173,747 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 3,875 | 0 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 45,000 | 45,000 | - | - | Restricted Stock Units | |
| James Loerop | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 155,000 | 155,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,050 | 87,684 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,050 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 6,638 | 153,114 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 7,100 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 3,875 | 118,571 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 6,638 | 0 | - | - | Restricted Stock Unit | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 27,905 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 3,875 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 27,905 | 146,476 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 7,100 | 160,214 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 2,333 | 87,675 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.22 per share. | 01 Sep 2021 | 1,041 | 86,634 (0%) | 0% | 17.2 | 17,926 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 2,333 | 0 | - | - | Restricted Stock Units | |
| David N. Gordon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 13 Jul 2021 | 2,631 | 147,447 (0%) | 0% | 17.0 | 44,675 | Common Stock |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 6,000 | 6,000 | - | - | Restricted Stock Units | |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2021 | 6,000 | 150,078 (0%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.51 per share. | 01 Jun 2021 | 27,743 | 1,237,699 (2%) | 0% | 21.5 | 596,696 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 73,015 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 73,015 | 1,265,442 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.30 per share. | 01 Jun 2021 | 5,517 | 1,232,182 (2%) | 0% | 22.3 | 123,038 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 33,189 | 176,807 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.32 per share. | 01 Jun 2021 | 2,517 | 146,807 (0%) | 0% | 22.3 | 56,173 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 01 Jun 2021 | 12,483 | 149,324 (0%) | 0% | 21.5 | 268,412 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.57 per share. | 01 Jun 2021 | 5,254 | 161,807 (0%) | 0% | 23.6 | 123,851 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 01 Jun 2021 | 9,746 | 167,061 (0%) | 0% | 22.7 | 221,448 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 33,189 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 22.31 per share. | 01 Jun 2021 | 2,387 | 131,688 (0%) | 0% | 22.3 | 53,257 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 21.51 per share. | 01 Jun 2021 | 12,732 | 134,075 (0%) | 0% | 21.5 | 273,822 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.51 per share. | 01 Jun 2021 | 12,587 | 172,322 (0%) | 0% | 21.5 | 270,748 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 33,189 | 184,909 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 33,189 | 0 | - | - | Restricted Stock Units | |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.30 per share. | 01 Jun 2021 | 2,450 | 169,872 (0%) | 0% | 22.3 | 54,635 | Common Stock |
| David N. Gordon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 01 Jun 2021 | 9,115 | 186,877 (0%) | 0% | 22.7 | 207,024 | Common Stock |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 87,500 | 0 | - | - | Restricted Stock Units | |
| David N. Gordon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.26 per share. | 01 Jun 2021 | 6,800 | 144,078 (0%) | 0% | 22.3 | 151,401 | Common Stock |
| David N. Gordon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 01 Jun 2021 | 31,114 | 150,878 (0%) | 0% | 21.5 | 668,808 | Common Stock |
| David N. Gordon | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.57 per share. | 01 Jun 2021 | 4,885 | 181,992 (0%) | 0% | 23.6 | 115,142 | Common Stock |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 87,500 | 195,992 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.50 per share. | 01 Jun 2021 | 18,240 | 88,892 (0%) | 0% | 21.5 | 392,231 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 50,000 | 107,132 (0%) | 0% | - | Common Stock | |
| Joseph Monahan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.31 per share. | 01 Jun 2021 | 3,550 | 85,342 (0%) | 0% | 22.3 | 79,205 | Common Stock |
| Joseph Monahan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.32 per share. | 06 May 2021 | 11,898 | 146,720 (0%) | 0% | 23.3 | 277,438 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 06 May 2021 | 15,000 | 158,618 (0%) | 0% | 10.7 | 159,900 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 5,416 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 15,000 | 5,416 | - | - | Employee Stock Option (Right to Buy) | |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.99 per share. | 06 May 2021 | 2,100 | 143,618 (0%) | 0% | 24.0 | 50,376 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.23 per share. | 06 May 2021 | 3,316 | 145,718 (0%) | 0% | 23.2 | 77,016 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 06 May 2021 | 5,416 | 149,034 (0%) | 0% | 10.7 | 57,735 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.86 per share. | 06 May 2021 | 3,102 | 143,618 (0%) | 0% | 23.9 | 74,016 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.97 per share. | 03 May 2021 | 14,502 | 144,116 (0%) | 0% | 24.0 | 347,584 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 03 May 2021 | 15,000 | 158,618 (0%) | 0% | 10.7 | 159,900 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.46 per share. | 03 May 2021 | 10,661 | 147,957 (0%) | 0% | 24.5 | 260,745 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.91 per share. | 03 May 2021 | 4,339 | 143,618 (0%) | 0% | 24.9 | 108,074 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 03 May 2021 | 15,000 | 158,618 (0%) | 0% | 10.7 | 159,900 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 23.61 per share. | 03 May 2021 | 13,721 | 144,897 (0%) | 0% | 23.6 | 323,891 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.47 per share. | 03 May 2021 | 1,279 | 143,618 (0%) | 0% | 24.5 | 31,296 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.66 per share. | 03 May 2021 | 15,000 | 158,618 (0%) | 0% | 10.7 | 159,900 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 24.36 per share. | 03 May 2021 | 498 | 143,618 (0%) | 0% | 24.4 | 12,129 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 15,000 | 50,416 | - | - | Employee Stock Option (Right to Buy) | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 15,000 | 35,416 | - | - | Employee Stock Option (Right to Buy) | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 15,000 | 20,416 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.84 per share. | 22 Apr 2021 | 30,000 | 1,192,427 (2%) | 0% | 26.8 | 805,239 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.33 per share. | 22 Apr 2021 | 800 | 179,059 (0%) | 0% | 27.3 | 21,863 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 22 Apr 2021 | 29,200 | 179,859 (0%) | 0% | 26.6 | 777,797 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.79 per share. | 22 Apr 2021 | 27,239 | 151,820 (0%) | 0% | 25.8 | 702,584 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.84 per share. | 22 Apr 2021 | 30,000 | 209,059 (0%) | 0% | 26.8 | 805,218 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.44 per share. | 22 Apr 2021 | 100 | 151,720 (0%) | 0% | 26.4 | 2,644 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Mar 2021 | 7,500 | 114,696 (0%) | 0% | 0 | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 18,253 | 54,762 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 96,150 | 1,251,948 (3%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 96,150 | 192,300 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 73,100 | 73,100 | - | - | Restricted stock units | |
| Neal Walker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 255,800 | 255,800 | - | - | Employee Stock Option (Right to Buy) | |
| Neal Walker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.25 per share. | 01 Mar 2021 | 7,982 | 1,222,427 (2%) | 0% | 23.3 | 185,582 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 18,253 | 1,230,409 (2%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 01 Mar 2021 | 39,792 | 1,212,156 (2%) | 0% | 24.1 | 957,396 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 17,175 | 143,821 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 6,637 | 19,914 | - | - | Restricted stock units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 17,175 | 34,350 | - | - | Restricted stock units | |
| Kamil Ali-Jackson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 28,400 | 28,400 | - | - | Restricted stock units | |
| Kamil Ali-Jackson | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 99,500 | 99,500 | - | - | Employee Stock Option (Right to Buy) | |
| Kamil Ali-Jackson | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.25 per share. | 01 Mar 2021 | 1,906 | 143,618 (0%) | 0% | 23.3 | 44,315 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 6,637 | 145,524 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 01 Mar 2021 | 4,934 | 138,887 (0%) | 0% | 24.1 | 118,712 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 8,297 | 24,892 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 25,750 | 51,500 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 33,200 | 33,200 | - | - | Restricted stock units | |
| Frank Ruffo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 116,000 | 116,000 | - | - | Employee Stock Option (Right to Buy) | |
| Frank Ruffo | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.25 per share. | 01 Mar 2021 | 2,844 | 239,059 (0%) | 0% | 23.3 | 66,123 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 8,297 | 241,903 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 01 Mar 2021 | 7,333 | 233,606 (0%) | 0% | 24.1 | 176,432 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 25,750 | 240,939 (0%) | 0% | - | Common Stock | |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 8,297 | 110,772 (0%) | 0% | - | Common Stock | |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 8,297 | 24,892 | - | - | Restricted stock units | |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 20,600 | 41,200 | - | - | Restricted stock units | |
| David N. Gordon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 28,400 | 28,400 | - | - | Restricted stock units | |
| David N. Gordon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 99,500 | 99,500 | - | - | Employee Stock Option (Right to Buy) | |
| David N. Gordon | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.25 per share. | 01 Mar 2021 | 2,280 | 108,492 (0%) | 0% | 23.3 | 53,010 | Common Stock |
| David N. Gordon | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 01 Mar 2021 | 5,660 | 102,475 (0%) | 0% | 24.1 | 136,180 | Common Stock |
| David N. Gordon | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 20,600 | 108,135 (0%) | 0% | - | Common Stock | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 6,632 | 0 | - | - | Option Grant (right to buy) | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 8,000 | 0 | - | - | Option Grant (right to buy) | |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.32 per share. | 02 Feb 2021 | 6,632 | 30,841 (0%) | 0% | 18.3 | 121,498 | Common Stock |
| Anand Mehra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.35 per share. | 02 Feb 2021 | 8,000 | 24,209 (0%) | 0% | 18.4 | 146,800 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 10,800 | 1,159,114 (2%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.35 per share. | 01 Feb 2021 | 3,316 | 1,155,798 (2%) | 0% | 21.4 | 70,797 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 10,800 | 10,800 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 3,875 | 127,964 (0%) | 0% | - | Common Stock | |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 3,875 | 3,875 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.35 per share. | 01 Feb 2021 | 1,318 | 126,646 (0%) | 0% | 21.3 | 28,139 | Common Stock |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 3,875 | 3,875 | - | - | Restricted Stock Units | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 3,875 | 216,497 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.35 per share. | 01 Feb 2021 | 1,308 | 215,189 (0%) | 0% | 21.4 | 27,926 | Common Stock |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 3,034 | 1,149,185 (2%) | 0% | - | Common Stock | |
| Neal Walker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 3,034 | 0 | - | - | Restricted Stock Units | |
| Neal Walker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 15 Dec 2020 | 871 | 1,148,314 (2%) | 0% | 4.6 | 3,998 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 1,734 | 0 | - | - | Restricted Stock Units | |
| Kamil Ali-Jackson | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 15 Dec 2020 | 498 | 124,089 (0%) | 0% | 4.6 | 2,286 | Common Stock |
| Kamil Ali-Jackson | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 1,734 | 124,587 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 1,300 | 212,992 (0%) | 0% | - | Common Stock | |
| Frank Ruffo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 1,300 | 0 | - | - | Restricted Stock Units | |
| Frank Ruffo | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 15 Dec 2020 | 370 | 212,622 (0%) | 0% | 4.6 | 1,698 | Common Stock |